Contact this trialFirst, we need to learn more about you.
Anti-cancer agent
CC-92480 + Dexamethasone for Multiple Myeloma
Recruiting1 awardPhase 1 & 2
Toronto, Ontario
This trial is testing a new way to treat Multiple Myeloma that has relapsed or become refractory to other treatments. The trial will assess the safety and efficacy of the new treatment.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service